1996
The Center for Genetic Engineering and Biotechnology cloned and expressed recombinant human interferon gamma in Escherichia coli and its production was scaled up for the drug Heberon® Gamma R, useful in the treatment of juvenile rheumatoid arthritis , chemoresistant pulmonary tuberculosis, idiopathic pulmonary fibrosis, and atypical pulmonary mycobacteriosis. The Diagnostic Kits Production Plant has been completed.